vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and GoPro, Inc. (GPRO). Click either name above to swap in a different company.

GoPro, Inc. is the larger business by last-quarter revenue ($201.7M vs $196.0M, roughly 1.0× Axsome Therapeutics, Inc.). On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 0.4%). GoPro, Inc. produced more free cash flow last quarter ($15.0M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 13.9%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

GoPro, Inc. is an American technology company founded in 2002 by Nick Woodman. It manufactures action cameras and develops its own mobile apps and video-editing software. Founded as Woodman Labs, Inc, the company is based in San Mateo, California.

AXSM vs GPRO — Head-to-Head

Bigger by revenue
GPRO
GPRO
1.0× larger
GPRO
$201.7M
$196.0M
AXSM
Growing faster (revenue YoY)
AXSM
AXSM
+64.6% gap
AXSM
65.0%
0.4%
GPRO
More free cash flow
GPRO
GPRO
$33.7M more FCF
GPRO
$15.0M
$-18.7M
AXSM
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
61.7%
13.9%
GPRO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AXSM
AXSM
GPRO
GPRO
Revenue
$196.0M
$201.7M
Net Profit
$-28.6M
Gross Margin
31.8%
Operating Margin
-13.8%
-4.1%
Net Margin
-14.6%
Revenue YoY
65.0%
0.4%
Net Profit YoY
61.9%
EPS (diluted)
$-0.55
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
GPRO
GPRO
Q4 25
$196.0M
$201.7M
Q3 25
$171.0M
$162.9M
Q2 25
$150.0M
$152.6M
Q1 25
$121.5M
$134.3M
Q4 24
$118.8M
$200.9M
Q3 24
$104.8M
$258.9M
Q2 24
$87.2M
$186.2M
Q1 24
$75.0M
$155.5M
Net Profit
AXSM
AXSM
GPRO
GPRO
Q4 25
$-28.6M
Q3 25
$-47.2M
$-21.3M
Q2 25
$-48.0M
$-16.4M
Q1 25
$-59.4M
$-46.7M
Q4 24
$-74.9M
Q3 24
$-64.6M
$-8.2M
Q2 24
$-79.3M
$-47.8M
Q1 24
$-68.4M
$-339.1M
Gross Margin
AXSM
AXSM
GPRO
GPRO
Q4 25
31.8%
Q3 25
35.1%
Q2 25
35.8%
Q1 25
32.1%
Q4 24
34.7%
Q3 24
35.5%
Q2 24
30.5%
Q1 24
34.1%
Operating Margin
AXSM
AXSM
GPRO
GPRO
Q4 25
-13.8%
-4.1%
Q3 25
-27.0%
-9.8%
Q2 25
-24.5%
-9.2%
Q1 25
-46.9%
-33.7%
Q4 24
-61.1%
-19.5%
Q3 24
-59.8%
-3.1%
Q2 24
-89.5%
-25.0%
Q1 24
-89.7%
-26.6%
Net Margin
AXSM
AXSM
GPRO
GPRO
Q4 25
-14.6%
Q3 25
-27.6%
-13.0%
Q2 25
-32.0%
-10.8%
Q1 25
-48.9%
-34.8%
Q4 24
-63.1%
Q3 24
-61.7%
-3.2%
Q2 24
-91.0%
-25.7%
Q1 24
-91.1%
-218.1%
EPS (diluted)
AXSM
AXSM
GPRO
GPRO
Q4 25
$-0.55
$-0.06
Q3 25
$-0.94
$-0.13
Q2 25
$-0.97
$-0.10
Q1 25
$-1.22
$-0.30
Q4 24
$-1.54
$-0.22
Q3 24
$-1.34
$-0.05
Q2 24
$-1.67
$-0.31
Q1 24
$-1.44
$-2.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
GPRO
GPRO
Cash + ST InvestmentsLiquidity on hand
$322.9M
$49.7M
Total DebtLower is stronger
$44.3M
Stockholders' EquityBook value
$88.3M
$76.5M
Total Assets
$689.8M
$428.0M
Debt / EquityLower = less leverage
0.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
GPRO
GPRO
Q4 25
$322.9M
$49.7M
Q3 25
$325.3M
$152.8M
Q2 25
$303.0M
$58.6M
Q1 25
$300.9M
$69.6M
Q4 24
$315.4M
$102.8M
Q3 24
$327.3M
$130.2M
Q2 24
$315.7M
$133.0M
Q1 24
$331.4M
$133.7M
Total Debt
AXSM
AXSM
GPRO
GPRO
Q4 25
$44.3M
Q3 25
$43.9M
Q2 25
Q1 25
Q4 24
$0
Q3 24
$93.1M
Q2 24
$92.9M
Q1 24
$92.7M
Stockholders' Equity
AXSM
AXSM
GPRO
GPRO
Q4 25
$88.3M
$76.5M
Q3 25
$73.7M
$80.5M
Q2 25
$73.1M
$97.9M
Q1 25
$53.2M
$110.0M
Q4 24
$57.0M
$151.7M
Q3 24
$92.9M
$183.9M
Q2 24
$102.9M
$184.7M
Q1 24
$144.0M
$224.9M
Total Assets
AXSM
AXSM
GPRO
GPRO
Q4 25
$689.8M
$428.0M
Q3 25
$669.3M
$538.6M
Q2 25
$639.8M
$439.0M
Q1 25
$596.7M
$462.5M
Q4 24
$568.5M
$543.7M
Q3 24
$561.5M
$661.6M
Q2 24
$548.2M
$556.8M
Q1 24
$545.7M
$575.8M
Debt / Equity
AXSM
AXSM
GPRO
GPRO
Q4 25
0.58×
Q3 25
0.55×
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.51×
Q2 24
0.50×
Q1 24
0.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
GPRO
GPRO
Operating Cash FlowLast quarter
$-18.7M
$15.6M
Free Cash FlowOCF − Capex
$-18.7M
$15.0M
FCF MarginFCF / Revenue
-9.6%
7.4%
Capex IntensityCapex / Revenue
0.0%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-93.9M
$-24.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
GPRO
GPRO
Q4 25
$-18.7M
$15.6M
Q3 25
$1.0M
$12.2M
Q2 25
$-32.4M
$8.8M
Q1 25
$-43.4M
$-57.2M
Q4 24
$-26.2M
$-25.1M
Q3 24
$-18.6M
$-2.2M
Q2 24
$-30.1M
$605.0K
Q1 24
$-53.5M
$-98.4M
Free Cash Flow
AXSM
AXSM
GPRO
GPRO
Q4 25
$-18.7M
$15.0M
Q3 25
$988.0K
$11.2M
Q2 25
$-32.4M
$8.3M
Q1 25
$-43.7M
$-58.5M
Q4 24
$-26.2M
$-25.5M
Q3 24
$-18.7M
$-4.2M
Q2 24
$-30.2M
$-111.0K
Q1 24
$-53.6M
$-99.4M
FCF Margin
AXSM
AXSM
GPRO
GPRO
Q4 25
-9.6%
7.4%
Q3 25
0.6%
6.9%
Q2 25
-21.6%
5.4%
Q1 25
-36.0%
-43.5%
Q4 24
-22.1%
-12.7%
Q3 24
-17.9%
-1.6%
Q2 24
-34.6%
-0.1%
Q1 24
-71.4%
-63.9%
Capex Intensity
AXSM
AXSM
GPRO
GPRO
Q4 25
0.0%
0.3%
Q3 25
0.0%
0.6%
Q2 25
0.0%
0.3%
Q1 25
0.3%
1.0%
Q4 24
0.0%
0.2%
Q3 24
0.1%
0.8%
Q2 24
0.1%
0.4%
Q1 24
0.1%
0.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Segment breakdown not available.

GPRO
GPRO

Subscription And Services$106.3M53%
Other$95.4M47%

Related Comparisons